Mu-Ru Wang
Impact in
- Cancer Research top 10%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
-
- Circular RNAs in diseases
- RNA modifications and cancer
- Epigenetics and DNA Methylation
- Cancer-related gene regulation
- Inflammasome and immune disorders
Papers in
-
- Inflammasome and immune disorders 3
- Epigenetics and DNA Methylation 2
- Heme Oxygenase-1 and Carbon Monoxide 2
- RNA modifications and cancer 2
- Co-authors
- Peiyuan Li (9 shared papers)Jiaqi Sheng (5 shared papers)Lian Liu (4 shared papers)Dean Tian (9 shared papers)Dan Fang (6 shared papers)Xingxing He (3 shared papers)Lei Yu (2 shared papers)Wenjie Huang (1 shared paper)
In The Last Decade
Mu-Ru Wang
14 papers receiving 320 citations
Peers
Comparison fields: 5 of 58
- Cancer Research 161
- Molecular Biology 250
- Immunology 34
- Modeling and Simulation 7
- Epidemiology 52
Countries citing papers authored by Mu-Ru Wang
This map shows the geographic impact of Mu-Ru Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mu-Ru Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mu-Ru Wang more than expected).
Fields of papers citing papers by Mu-Ru Wang
This network shows the impact of papers produced by Mu-Ru Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mu-Ru Wang. The network helps show where Mu-Ru Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Mu-Ru Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 62 | |
| 2 | 2020 | 59 | |
| 3 | 2022 | 50 | |
| 4 | Circular RNAs in digestive system cancer: potential biomarkers and therapeutic targets. | 2018 | 49 |
| 5 | 2020 | 33 | |
| 6 | 2020 | 15 | |
| 7 | 2020 | 13 | |
| 8 | 2021 | 13 | |
| 9 | 2022 | 8 | |
| 10 | 2019 | 8 | |
| 11 | 2023 | 6 | |
| 12 | 2020 | 5 | |
| 13 | 2022 | 1 | |
| 14 | 2025 | 1 |
About Mu-Ru Wang
Mu-Ru Wang is a scholar working on Molecular Biology, Epidemiology, Cancer Research, Surgery and Pulmonary and Respiratory Medicine, having authored 14 papers that have together received 323 indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (3 papers), Inflammasome and immune disorders (3 papers), Epigenetics and DNA Methylation (2 papers), Heme Oxygenase-1 and Carbon Monoxide (2 papers), interferon and immune responses (2 papers), RNA modifications and cancer (2 papers), Infection Control and Ventilation (1 paper) and MicroRNA in disease regulation (1 paper). The work is most often cited by research in Cancer Research (161 citations), Molecular Biology (250 citations), Immunology (34 citations), Modeling and Simulation (7 citations) and Epidemiology (52 citations). Mu-Ru Wang has collaborated with scholars based in China and Taiwan. Frequent co-authors include Peiyuan Li, Jiaqi Sheng, Lian Liu, Dean Tian, Dan Fang, Xingxing He, Lei Yu, Wenjie Huang, Wei Yan and Zonglong Wu. Their work appears in journals such as International Journal of Medical Sciences, Cancer Biology & Therapy, BioMed Research International, Biomedicine & Pharmacotherapy and Cell Death and Disease.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.